{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:39:43Z","timestamp":1789821583094,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer New York","isbn-type":[{"value":"9781493928057","type":"print"},{"value":"9781493928064","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-2806-4_27","type":"book-chapter","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T15:46:57Z","timestamp":1437580017000},"page":"397-415","source":"Crossref","is-referenced-by-count":13,"title":["Experiences with CPP-Based Self Assembling Peptide Systems for Topical Delivery of Botulinum Toxin"],"prefix":"10.1007","author":[{"given":"Jane","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"27_CR1","first-page":"734","volume":"79","author":"AB Scott","year":"1981","unstructured":"Scott AB (1981) Botulinum toxin injection of eye muscles to correct strabismus. Trauma Am Opthalmol Soc 79:734\u2013770","journal-title":"Trauma Am Opthalmol Soc"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJM199907083410209","volume":"341","author":"M Hallett","year":"1999","unstructured":"Hallett M (1999) One man\u2019s poison-clinical applications of botulinum toxin. N Engl J Med 341:118\u2013120","journal-title":"N Engl J Med"},{"key":"27_CR3","first-page":"17","volume":"1","author":"JM Spencer","year":"2002","unstructured":"Spencer JM (2002) Botulinum toxin B. The new option in cosmetic injection. J Drugs Dermatol 1:17\u201322","journal-title":"J Drugs Dermatol"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jaad.2005.03.060","volume":"53","author":"A Carruthers","year":"2005","unstructured":"Carruthers A, Carruthers J (2005) Botulinum toxin type A. J Am Acad Dermatol 53:284\u2013290","journal-title":"J Am Acad Dermatol"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/14764170701411470","volume":"9","author":"J Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A (2007) The evolution of botulinum toxin type A for cosmetic applications. J Cosmet Laser Ther 9:186\u2013192","journal-title":"J Cosmet Laser Ther"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","volume":"18","author":"J Carruthers","year":"1992","unstructured":"Carruthers J, Carruthers A (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17\u201321","journal-title":"J Dermatol Surg Oncol"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","volume":"114","author":"J Carruthers","year":"2004","unstructured":"Carruthers J, Fagien S, Matarasso SL, BOTOX Consensus Group (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114:1S\u201322S","journal-title":"Plast Reconstr Surg"},{"key":"27_CR8","unstructured":"The American Society for Aesthetic Plastic Surgery, Cosmetic Surgery National Data Bank. 2006 statistics. www.surgery.org\/download\/2006stats.pdf. Accessed 30 March 2007."},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2230.1996.tb00093.x","volume":"21","author":"KO Bushara","year":"1996","unstructured":"Bushara KO, Park DM, Jones JC, Schutta HS (1996) Botulinum toxin-a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 21:276\u2013278","journal-title":"Clin Exp Dermatol"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1365-2133.1996.tb07974.x","volume":"134","author":"P Schnider","year":"1996","unstructured":"Schnider P, Binder M, Berger T, Auff E (1996) Botulinum A toxin injection in focal hyperhidrosis. Br J Dermatol 134:1160\u20131161","journal-title":"Br J Dermatol"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archderm.134.3.301","volume":"134","author":"M Naumann","year":"1998","unstructured":"Naumann M, Hofmann U, Bergmann I, Hamm H, Tiyka KV, Reiners K (1998) Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 134:301\u2013304","journal-title":"Arch Dermatol"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM200102153440704","volume":"344","author":"M Heckmann","year":"2001","unstructured":"Heckmann M, Ceballos-Baumann AO, Plewig G (2001) Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344:488\u2013493","journal-title":"N Engl J Med"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","volume":"323","author":"M Naumann","year":"2001","unstructured":"Naumann M, Lowe NJ (2001) Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 323:596\u2013599","journal-title":"BMJ"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1067\/mjd.2002.124070","volume":"47","author":"NJ Lowe","year":"2002","unstructured":"Lowe NJ, Lask G, Yamauchi P, Moore D (2002) Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow\u2019s feet. J Am Acad Dermatol 47:834\u2013840","journal-title":"J Am Acad Dermatol"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00042728-200503000-00001","volume":"31","author":"NJ Lowe","year":"2005","unstructured":"Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, BOTOX Facial Aesthetics Study Team (2005) Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow\u2019s feet. Dermatol Surg 31:257\u2013262","journal-title":"Dermatol Surg"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00006534-200107000-00033","volume":"108","author":"SL Matarasso","year":"2001","unstructured":"Matarasso SL, Matarasso A (2001) Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg 108:208\u2013214","journal-title":"Plast Reconstr Surg"},{"key":"27_CR17","unstructured":"Allergan, Inc. (2006) BOTOX cosmetic (botulinum toxin type A) prescribing information. Irvine, CA"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","volume":"8","author":"KR Aoki","year":"2001","unstructured":"Aoki KR, Guyer B (2001) Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 8:21\u201329","journal-title":"Eur J Neurol"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neuro.2004.12.012","volume":"26","author":"C Grumelli","year":"2005","unstructured":"Grumelli C, Verderio C, Pozzi D, Rossetto O, Montecucco C, Matteoli M (2005) Internalization and mechanism of action for clostridial toxins in neurons. Neurotoxicology 26:761\u2013767","journal-title":"Neurotoxicology"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","volume":"52","author":"JJ Dutton","year":"2007","unstructured":"Dutton JJ, Fowler AM (2007) Botulinum toxin in ophthalmology. Surv Ophthalmol 52:13\u201331","journal-title":"Surv Ophthalmol"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.gt.3301383","volume":"8","author":"KG Ford","year":"2001","unstructured":"Ford KG, Souberbielle BE, Darling D, Farzaneh F (2001) Protein transduction: an alternative to genetic intervention? Gene Ther 8:1\u20134","journal-title":"Gene Ther"},{"key":"27_CR22","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","volume":"39","author":"KR Aoki","year":"2001","unstructured":"Aoki KR (2001) A comparison of the safety margins of botulinum toxin serotypes A, B, and F in mice. Toxicon 39:1815\u20131820","journal-title":"Toxicon"},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/1523-1747.ep12524440","volume":"87","author":"MD Koone","year":"1986","unstructured":"Koone MD, Black HS (1986) A mode of action for butylated hydroxytoluene-mediated photoprotection. J Invest Dermatol 87:343\u2013347","journal-title":"J Invest Dermatol"},{"key":"27_CR24","doi-asserted-by":"crossref","first-page":"d1044","DOI":"10.2741\/A830","volume":"7","author":"HS Black","year":"2002","unstructured":"Black HS (2002) Pro-oxidant and anti-oxidant mechanism(s) of BHT and beta-carotene in photocarcinogenesis. Front Biosci 7:d1044\u2013d1055","journal-title":"Front Biosci"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1073\/pnas.88.3.946","volume":"88","author":"KZ Guyton","year":"1991","unstructured":"Guyton KZ, Bhan P, Kuppusamy P, Zweier JL, Trush MA, Kensler TW (1991) Free radical-derived quinone methide mediates skin tumor promotion by butylated hydroxytoluene hydroperoxide: expanded role for electrophiles in multistage carcinogenesis. Proc Natl Acad Sci 88:946\u2013950","journal-title":"Proc Natl Acad Sci"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.toxlet.2004.02.012","volume":"150","author":"F Muhammad","year":"2004","unstructured":"Muhammad F, Brooks JD, Riviere JE (2004) Comparative mixture effects of JP-8(100) additives on the dermal absorption and disposition of jet fuel hydrocarbons in different membrane model systems. Toxicol Lett 150:351\u2013365","journal-title":"Toxicol Lett"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1111\/j.1524-4725.2006.32335.x","volume":"33","author":"RG Glogau","year":"2007","unstructured":"Glogau RG (2007) Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg 33:S76\u2013S80","journal-title":"Dermatol Surg"}],"container-title":["Methods in Molecular Biology","Cell-Penetrating Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2806-4_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:26:06Z","timestamp":1675866366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-2806-4_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9781493928057","9781493928064"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2806-4_27","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}